Topical Anti-TNF[alpha] Agent Licaminlimab Relieves Persistent Ocular Discomfort in Severe Dry Eye D...
Topical Anti-TNF[alpha] Agent Licaminlimab Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study
About this item
Full title
Author / Creator
Publisher
Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
Purpose: To assess the efficacy, safety, and pharmacokinetics of new topical ocular anti-TNF[alpha] antibody fragment licaminlimab in the relief of persistent ocular discomfort in severe dry eye disease (DED). Patients and Methods: Patients with [greater than or equal to] 6-month history of DED, regular use of artificial tears, and best-corrected v...
Alternative Titles
Full title
Topical Anti-TNF[alpha] Agent Licaminlimab Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A714421151
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A714421151
Other Identifiers
ISSN
1177-5483
DOI
10.2147/OPTH.S366836
